halothane has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, S; Koide, A; Maekawa, I; Mayumi, T; Okamoto, T; Sato, Y | 1 |
| Pillans, PI | 1 |
| KIRCHNER, E; MUELLER, K | 1 |
3 other study(ies) available for halothane and cardiovascular agents
| Article | Year |
|---|---|
[The roles of anesthetics and daily used drugs in cardiovascular changes during normovolemic hemodilution (NVHD)].
Topics: Cardiovascular Agents; Epinephrine; Fentanyl; Halothane; Hemodilution; Hemodynamics; Humans; Norepinephrine | 1991 |
Drug associated hepatic reactions in New Zealand: 21 years experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Cause of Death; Clavulanic Acids; Diclofenac; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Floxacillin; Halothane; Humans; Liver; Male; Middle Aged; New Zealand; Penicillins; Perhexiline; Steroids | 1996 |
[Does halothane prolong the effect of short-acting muscle relaxants of the suxamethonium type?].
Topics: Anesthetics; Cardiovascular Agents; Halothane; Humans; Succinylcholine | 1961 |